To address this in the setting of T1D, transgenic plant cells expressing disease-related autoantigens16, 17, 18, 19 (i.e., insulin, glutamic acid decarboxylase 65 (GAD)) have been used to deliver intact protein to the small intestine’s gut associated lymphoid tissue. This evidence concerns the gene INS and type 1 diabetes mellitus.